Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection
- 15 January 1996
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 81 (2) , 213-218
- https://doi.org/10.1016/0049-3848(95)00238-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Atheroembolism in HIV-positive individualsThe Lancet, 1992
- Coronary lesions in young HIV-positive subjects at necropsyThe Lancet, 1992
- Apolipoprotein All in HIV-1 infectionThe Lancet, 1992
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992
- International Federation of Clinical Chemistry study on the standardization of apolipoproteins A-l and BCurrent Opinion in Lipidology, 1991
- Hypertriglyceridemia in the acquired immunodeficiency syndromeThe American Journal of Medicine, 1989
- Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.Journal of Clinical Investigation, 1988
- Lipoprotein abnormalities associated with a viral syndromePublished by American Medical Association (AMA) ,1982
- ACCELERATED PROSTACYCLIN DEGRADATION IN THROMBOTIC THROMBOCYTOPENIC PURPURAThe Lancet, 1981
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955